Je was op zoek naar: famotidine (Engels - Sloveens)

famotidine
famotidin

with famotidine.
očasno s famotidinom.

famotidine /lamivudine
famotidin/lamivudin

famotidine 40 mg bid
(15, 97; 30, 34)

hydroxide antacids nor famotidine
hidroksidni antacidi niti

famotidine (40 mg once daily)
famotidin (40 mg enkrat dnevno)

famotidine 20 mg twice daily.
famotidinu 20 mg dvakrat na dan.

famotidine/tenofovir disoproxil fumarate
famotidin/dizoproksiltenofovirijev fumarat

famotidine dosed simultaneously with epclusad
famotidin uporabljen sočasno z zdravilom epclusad

famotidine dosed 12 hours prior to harvonid
famotidin uporabljen 12 ur pred zdravilom harvonid

h2 blockers such as cimetidine, ranitidine, famotidine or nizatidine.
antagonisti h2, kot so cimetidin, ranitidin, famotidin ali nizatidin.

famotidine 40 mg single dose (daclatasvir 60 mg single dose)
famotidin, enkratni 40-mg

famotidine/efavirenz (40 mg single dose/400 mg single dose)
(enkratni odmerek 30 ml/enkratni odmerek 400 mg) famotidin/efavirenz (enkratni odmerek 40 mg/enkratni odmerek 400 mg)

famotidine (40 mg single dose taken 2 hours before rilpivirine)/ rilpivirine1
famotidin (40 mg enkratni odmerek, vzet 2 uri pred rilpivirinom)/ rilpivirin1

the administration of apixaban 10 mg with famotidine 40 mg had no effect on apixaban auc or cmax.
pri sočasni uporabi apiksabana v odmerku 10 mg in famotidina v odmerku 40 mg učinkov na vrednosti auc ali cmax apiksabana niso opazili.

neither aluminium/magnesium hydroxide antacids nor famotidine altered the absorption of efavirenz.
niti aluminijevi/magnezijevi hidroksidni antacidi niti famotidin niso spremenili absorpcije efavirenza.

no clinically significant pharmacokinetic or pharmacodynamic interactions were observed when apixaban was coadministered with atenolol or famotidine.
pri sočasni uporabi apiksabana in atenolola ali famotidina niso poročali o klinično pomembnih farmakokinetičnih ali farmakodinamičnih interakcijah.

a gastric acid blocker, the h2 antagonist famotidine, reduces aripiprazole rate of absorption but this effect is deemed not clinically relevant.
zaviralec izločanja želodčne kisline, antagonist h2 famotidin, zmanjša hitrost absorpcije aripiprazola, vendar ta učinek ne velja za klinično pomembnega.

famotidine (40 mg single dose)/ sofosbuvir/ velpatasvir (400/ 100 mg single dose)c
famotidin (40 mg enkratni odmerek)/sofosbuvir/velpatasvir (400/100 mg enkratni odmerek)c

h2-receptor antagonists may be administered simultaneously with or staggered from epclusa at a dose that does not exceed doses comparable to famotidine 40 mg twice daily.
antagoniste receptorjev h2 se lahko uporablja sočasno z zdravilom epclusa ali s časovnim zamikom, v odmerku, ki ne presega odmerkov, primerljivih s famotidinom 40 mg dvakrat na dan.